Efficacy and brain mechanism of parietal magnetic stimulation inhibition in the treatment of obsessive-compulsive disorder

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200055381

Enrollment

Unknown

Registered

2022-01-08

Start date

2022-01-11

Completion date

Unknown

Last updated

2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-compulsive disorder

Interventions

Active stimulation group :Repetitive transcranial magnetic stimulation

Pseudo-stimulation group:Pseudo-repetitive transcranial magnetic stimulation

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years; 2. Use the Brief International Neuropsychiatric Interview (MINI) for rapid screening of various mental disorders to ensure compliance with the diagnostic criteria for OCD in DSM-5; 3. Moderate or above severity: Y-BOCS>16 points; 4. Have not taken antidepressants in the past 1 week, or have taken them but the effect is not good.

Exclusion criteria

Exclusion criteria: 1. Combined with depression, bipolar disorder, schizophrenia and other mental diseases, but not ruled out combined with generalized anxiety; 2. Combined with neurological diseases; 3. A history of traumatic brain injury or surgery; 4. EEG and MRI examinations are contraindicated; 5. Pregnancy and lactation.

Design outcomes

Primary

Measure	Time frame
Yale-Brown Obsessive-Compulsive Scale;	—

Secondary

Measure	Time frame
Hamilton depression scale;Hamilton anxiety scale;	—

Countries

China

Contacts

Public ContactChen Gang

32732752@qq.com+86 13770419126

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026